ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Interferon-Driven Biomarkers and Synergistic Therapy for PRMT5 Inhibition in Triple-Negative Breast Cancer.

Ziwen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.